- Previous Close
0.0250 - Open
0.0250 - Bid 0.0210 x --
- Ask 0.0230 x --
- Day's Range
0.0250 - 0.0250 - 52 Week Range
0.0200 - 0.0500 - Volume
138,978 - Avg. Volume
50,405 - Market Cap (intraday)
5.336M - Beta (5Y Monthly) -0.22
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.
inhalerx.com.auRecent News: IRX.AX
View MorePerformance Overview: IRX.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IRX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IRX.AX
View MoreValuation Measures
Market Cap
5.34M
Enterprise Value
5.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-69.85%
Return on Equity (ttm)
-402.12%
Revenue (ttm)
401.81k
Net Income Avi to Common (ttm)
-1.21M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
194.91k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-95.17k